University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, ...

Currently, a class of drugs called CDK4/6 inhibitors is being studied to treat patients with castration-resistant prostate cancer. However, about 15% of advanced prostate cancers do not have the RB1 ...

DNA aptamers are powerful molecular tools in biosensing, bioimaging and therapeutics. However, a limited understanding of their tertiary structures and binding mechanisms hinders their further ...

A research team has gained new insights into the molecular processes of clathrin-mediated endocytosis—the central process by which cells take up nutrients, messenger substances and receptors. The ...